Biosenic Stock Quote 0R55 - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.845

Bid

3.75

Ask

3.94

Volume

1,372

0.00 Day's Range 0.00

3.845 52 Week Range 3.845

Market Cap

627.431M

Previous Close

3.845

Open

Last Trade

800

0.0095

(O)

Last Trade Time

07:02:51

Financial Volume

VWAP

Average Volume (3m)

24,499

Shares Outstanding

163,181,000

Dividend Yield

PE Ratio

-0.06

Earnings Per Share (EPS)

-0.18

Revenue

545k

Net Profit

-28.78M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.bonetherapeutics.com

Headquarters

Mont-saint-guibert, Walloon Brabant, Bel

Founded

1970

Biosenic Sa is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0R55. The last closing price for Biosenic was 3.85 €. Over the last year, Biosenic shares have traded in a share price range of 3.845 € to 3.845 €.

Biosenic currently has 163,181,000 shares outstanding. The market capitalization of Biosenic is 627.43 € million. Biosenic has a price to earnings ratio (PE ratio) of -0.06.

BioSenic S.A. : Transparency notification received from Mr François Rieger

BioSenic S.A. : Transparency notification received from Mr François Rieger PRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings...

BioSenic S.A. : Notification de transparence reçue de la part de Monsieur François Rieger

BioSenic S.A. : Notification de transparence reçue de la part de Monsieur François Rieger COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Article 14 de la loi du 2 mai 2007 relative à la...

BioSenic releases new in-depth analysis of its positive phase 2 clinical data for optimal administration scheme for its next late-stage trial of arsenic trioxide (ATO) targeting cGvHD

BioSenic releases new in-depth analysis of its positive phase 2 clinical data for optimal administration scheme for its next late-stage trial of arsenic trioxide (ATO) targeting cGvHD Press...

BioSenic réalise une nouvelle analyse approfondie de ses données cliniques positives de phase 2 en vue d'un schéma d'administration optimal pour son prochain essai clinique de phase avancée sur le trioxyde d'arsenic (ATO) ciblant la cGvHD

BioSenic réalise une nouvelle analyse approfondie de ses données cliniques positives de phase 2 en vue d'un schéma d'administration optimal pour son prochain essai clinique de phase...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	3.845	3.845	3.845	29525	3.845	DE
4	3.845	3.845	3.845	17830	3.845	DE
12	3.845	3.845	3.845	24499	3.845	DE
26	3.845	3.845	3.845	16040	3.845	DE
52	3.845	3.845	3.845	26129	3.845	DE
156	3.845	3.845	3.845	13202	3.845	DE
260	3.845	3.845	3.845	12337	3.845	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
POAIPredictive Oncology Inc	$ 2.2105 (106.59%)	118.11M
PBMPsyence Biomedical Ltd	$ 0.6266 (60.09%)	57.64M
XCURExicure Inc	$ 0.58 (45.40%)	17.17M
SLRXSalarius Pharmaceuticals Inc	$ 2.8775 (34.46%)	14.79M
GSHDGoosehead Insurance Inc	$ 85.105 (29.54%)	461.73k
TWOU2U Inc	$ 1.49 (-63.83%)	2.84M
KDLYKindly MD Inc	$ 1.99 (-38.20%)	513k
EZFLEzFill Holdings Inc	$ 3.914 (-37.12%)	94.71k
ATPCAgape ATP Corporation	$ 0.1079 (-32.14%)	3.69M
CMMBChemomab Therapeutics Ltd	$ 0.985 (-30.63%)	2.07M
NVDANVIDIA Corporation	$ 114.938 (0.60%)	214.3M
POAIPredictive Oncology Inc	$ 2.2105 (106.59%)	129.63M
SLNASelina Hospitality PLC	$ 0.0413 (-9.63%)	129.13M
SQQQProShares UltraPro Short QQQ	$ 9.10 (0.44%)	111.7M
PBMPsyence Biomedical Ltd	$ 0.6266 (60.09%)	63.14M